Novel therapy tested in mice could chase away cat allergies
Researchers develop injectable treatment that blocks release of histamine, a key chemical causing allergy symptoms. The treatment, GFD, successfully prevents immune cells from reacting to cat allergen in both passively and actively allergic mice.
SourceNIH/National Institute of Allergy and Infectious Diseases·JournalNature Medicine·DateMar 27, 2005